Correlation Between Aquestive Therapeutics and OrganiGram Holdings
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and OrganiGram Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and OrganiGram Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and OrganiGram Holdings, you can compare the effects of market volatilities on Aquestive Therapeutics and OrganiGram Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of OrganiGram Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and OrganiGram Holdings.
Diversification Opportunities for Aquestive Therapeutics and OrganiGram Holdings
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aquestive and OrganiGram is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and OrganiGram Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OrganiGram Holdings and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with OrganiGram Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OrganiGram Holdings has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and OrganiGram Holdings go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and OrganiGram Holdings
Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 1.08 times more return on investment than OrganiGram Holdings. However, Aquestive Therapeutics is 1.08 times more volatile than OrganiGram Holdings. It trades about 0.08 of its potential returns per unit of risk. OrganiGram Holdings is currently generating about 0.0 per unit of risk. If you would invest 86.00 in Aquestive Therapeutics on September 14, 2024 and sell it today you would earn a total of 276.00 from holding Aquestive Therapeutics or generate 320.93% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Aquestive Therapeutics vs. OrganiGram Holdings
Performance |
Timeline |
Aquestive Therapeutics |
OrganiGram Holdings |
Aquestive Therapeutics and OrganiGram Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aquestive Therapeutics and OrganiGram Holdings
The main advantage of trading using opposite Aquestive Therapeutics and OrganiGram Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, OrganiGram Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will offset losses from the drop in OrganiGram Holdings' long position.Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
OrganiGram Holdings vs. Cronos Group | OrganiGram Holdings vs. Aurora Cannabis | OrganiGram Holdings vs. SNDL Inc | OrganiGram Holdings vs. Canopy Growth Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |